Trevena
| Region | Nordamerika |
| ISIN | US89532E1091 |
| Sektor | Biotechnologie |
| Website | http://www.trevena.com/ |
At Trevena, our mission is to deliver innovative solutions to patients and healthcare providers confronting serious medical conditions. Our history is rooted in strong science – Trevena was founded to translate Nobel Prize-winning research into a new generation of groundbreaking medicines. Our novel approach to drug discovery has established us as pioneers in acute care medicine.
| Titel | Datum |
|---|---|
| Trevena's (TRVN) CEO Carrie Bourdow on Q3 2018 Results - Earnings Call Transcript | vor 8 Tagen |
| TREVENA INC - 10-Q, Quaterly Report | vor 10 Tagen |
| Trevena (TRVN) Reports Q3 Loss of $0.06, Announces Workforce Restructuring | vor 10 Tagen |
| Trevena to cut 1/3 of workforce after FDA rejection of oliceridine | vor 10 Tagen |
| TREVENA INC - 8-K, Current Report | vor 10 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| TrackX Holdings (1 Artikel) | |
| The Priceline Group (2 Artikel) | |
| United Internet (1 Artikel) | |
| Vapiano (2 Artikel) | |
| Alle anzeigen | |